Zeronda Tyler 4
4 · VYNE Therapeutics Inc. · Filed Jul 5, 2023
Insider Transaction Report
Form 4
Zeronda Tyler
CHIEF FINANCIAL OFFICER
Transactions
- Tax Payment
Common Stock
2023-06-30$4.10/sh−91$373→ 8,017 total
Footnotes (1)
- [F1]Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.